About the Authors
- Marcelo A. Barria
-
Affiliations George and Cynthia Mitchell Center for Neurodegenerative Diseases, University of Texas Medical Branch, Galveston, Texas, United States of America, Department of Neurology, University of Texas Houston Medical School, Houston, Texas, United States of America
- Abhisek Mukherjee
-
Affiliations George and Cynthia Mitchell Center for Neurodegenerative Diseases, University of Texas Medical Branch, Galveston, Texas, United States of America, Department of Neurology, University of Texas Houston Medical School, Houston, Texas, United States of America
- Dennisse Gonzalez-Romero
-
Affiliations George and Cynthia Mitchell Center for Neurodegenerative Diseases, University of Texas Medical Branch, Galveston, Texas, United States of America, Department of Neurology, University of Texas Houston Medical School, Houston, Texas, United States of America
- Rodrigo Morales
-
Affiliations George and Cynthia Mitchell Center for Neurodegenerative Diseases, University of Texas Medical Branch, Galveston, Texas, United States of America, Department of Neurology, University of Texas Houston Medical School, Houston, Texas, United States of America, Facultad de Ciencias, University of Chile, Santiago, Chile
- Claudio Soto
-
* E-mail: claudio.soto@uth.tmc.edu
Affiliations George and Cynthia Mitchell Center for Neurodegenerative Diseases, University of Texas Medical Branch, Galveston, Texas, United States of America, Department of Neurology, University of Texas Houston Medical School, Houston, Texas, United States of America
Competing Interests
Dr. Soto is an inventor on the PMCA technology and a Founder, Vice-President and Chief Scientific Officer of Amprion Inc, a biotech company focusing on the development of early and sensitive diagnosis for prion diseases and other disorders involving protein misfolding.
Author Contributions
Conceived and designed the experiments: MAB CS. Performed the experiments: MAB AM DGR RM. Analyzed the data: MAB AM DGR CS. Wrote the paper: CS.